Is IMUN or EQR a better dividend investment in 2026?

IMUN currently yields 2150.54% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: IMUN offers higher current income.

What is the dividend yield difference between IMUN and EQR?

IMUN has a forward dividend yield of 2150.54% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 2144.67 percentage points.

Home › Compare › IMUN vs EQR

IMUN vs EQR: Dividend Comparison 2026

IMUN yields 2150.54% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMUN wins by $19570427201.55M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMUN

● Live price

2150.54%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$19570427201.60M

Annual income

$17,930,297,390,180,752.00

Full IMUN calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — IMUN vs EQR

📍 IMUN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMUN	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMUN + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMUN pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMUN

Annual income on $10K today (after 15% tax)

$182,795.70/yr

After 10yr DRIP, annual income (after tax)

$15,240,752,781,653,638.00/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, IMUN beats the other by $15,240,752,781,648,984.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMUN + EQR for your $10,000?

IMUN: 50%EQR: 50%

100% EQR50/50100% IMUN

Portfolio after 10yr

$9785213600.82M

Annual income

$8,965,148,695,093,114.00/yr

Blended yield

91.62%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

IMUN

No analyst data

Altman Z

-99826.2

Piotroski

3/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMUN buys

EQR buys

No recent congressional trades found for IMUN or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMUNEQR

Forward yield	2150.54% ✓	5.87%
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$19570427201.60M ✓	$47.8K
Annual income after 10y	$17,930,297,390,180,752.00 ✓	$5,475.61
Total dividends collected	$19454647652.69M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: IMUN vs EQR ($10,000, DRIP)

Year	IMUN Portfolio	IMUN Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$225,754	$215,053.76	$11,380	$679.82	+$214.4K → IMUN
2	$4,778,865	$4,537,308.08	$13,014	$837.25	+$4.77M → IMUN
3	$94,877,803	$89,764,417.71	$14,961	$1,036.20	+$94.86M → IMUN
4	$1,767,079,443	$1,665,560,193.96	$17,297	$1,289.22	+$1767.06M → IMUN
5	$30,882,096,431	$28,991,321,427.19	$20,121	$1,613.15	+$30882.08M → IMUN
6	$506,560,143,158	$473,516,299,976.79	$23,561	$2,030.84	+$506560.12M → IMUN
7	$7,800,995,961,541	$7,258,976,608,361.72	$27,783	$2,573.54	+$7800995.93M → IMUN
8	$112,821,651,087,287	$104,474,585,408,437.92	$33,013	$3,284.39	+$112821651.05M → IMUN
9	$1,532,831,599,456,105	$1,412,112,432,792,708.50	$39,547	$4,223.51	+$1532831599.42M → IMUN
10	$19,570,427,201,598,784	$17,930,297,390,180,752.00	$47,791	$5,475.61	+$19570427201.55M → IMUN

IMUN vs EQR: Complete Analysis 2026

IMUN — Stock

Immune Therapeutics, Inc. does not have significant operations. The company was formerly known as TNI BioTech, Inc. and changed its name to Immune Therapeutics, Inc. in October 2014. Immune Therapeutics, Inc. is headquartered in Orlando, Florida.

Full IMUN Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this IMUN vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMUN vs SCHD IMUN vs JEPI IMUN vs O IMUN vs KO IMUN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.